Combretastatin: Interim Phase Ib data

Interim results from a dose-escalation, U.K. Phase Ib trial in 8 patients with inoperable non-small cell lung cancer (NSCLC) showed that CA4P in combination with radiotherapy reduced relative tumor bl...